Key Findings
The North America joint pain injections market is projected to grow with a CAGR of 8.69% during the forecasting years of 2022 to 2030. Some of the key factors propelling the market growth of the region include the increasing number of new product launches and approvals, as well as the surging demand for innovative therapeutic platforms for joint pain to enhance treatment outcomes.

Market Insights
The North America joint pain injections market growth analysis entails the assessment of Canada and the United States. Canada is the second-largest market in North America in terms of joint pain injections. The country’s market growth is determined by the increasing incidence of orthopedic conditions, integrated with the biopharmaceutical and pharmaceutical industry’s transformation. As the tenth-largest market across pharmaceutical sales, Canada has experienced significant developments in generic drug manufacturing, small-medium-sized biopharmaceutical and pharmaceutical companies, as well as contract research organizations (CROs).
On the other hand, the pharmaceutical sector in Canada accounts for 41%, with the research and development industry, equating to 31% of the overall healthcare sector. The increasing prevalence of orthopedic conditions in the country will likely augment the demand for advanced procedures in Canada. Moreover, the country’s economic burden of orthopedic conditions was the highest among all diseases, with a total annual cost of more than $20 billion. As a result, these factors are set to facilitate the joint pain injections market growth in North America over the forecasted period.

Competitive Insights
The top players operating in the market are Anika Therapeutics Inc, Bioventus, Fidia Pharma USA Inc, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments